Fluoride Chewable Tablets Class Action Settlements

Settlement Structure: Claims Made

Active: Closed

Closed Settlement Statement:

According to court documents, the claim submission deadline has passed. Please contact the claims administrator if you have any questions.

Case Summary:

The plaintiffs in this lawsuit allege that the labeling of the prescription multivitamin Chewable Tablets misrepresented the amount of fluoride contained in them from October 31, 2007 through December 31, 2015. 

Docket Number:


Company: Endo International plc

Filing Deadline: April 17, 2017

Class Period: October 31, 2007 to December 31, 2015

Objection Deadline: April 17, 2017

Exclusion Deadline: April 17, 2017

Final Approval Hearing: June 9, 2017

Proof of Purchase: Eligibility:

This settlement includes persons and entities who paid for Chewable Tablets between October 31, 2007 and December 31, 2015, branded “Qualitest Pharmaceuticals,” “Vintage Pharmaceuticals,” or “Physicians Total Care,” containing fluoride doses of 1 mg, 0.5 mg, or 0.25 mg.

Typical Settlement Amount:

Settlement shares have not been calculated at this point, but your share will depend on the number of tablets purchased and the number of valid claim forms submitted.

Total Settlement Amount: $15,500,000

Class Representative Proposed Incentive Fee:


Law Firms:
Buckner and Mills
McCabe Rabin PA

Claim Form: Consumer Proof of Claim Form

Case Name: Mahoney v. Endo Health Solutions, Inc., et al.

Settlement Website: Fluoride Tablets Settlement

Claims Administrator:
AB Data

Claims Administrator Contact Information:

Fluoride Tablet Settlement
c/o A.B. Data, Ltd.
P.O. Box 173017
Milwaukee, WI 53217

Tags: Deceptive Advertising, Deceptive Labels, False Health Claims, Mislabeled Ingredients